Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparing Femoral Nerve Catheters to Single Shot Femoral Nerve Blocks for Total Knee Replacement Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02106481
Recruitment Status : Completed
First Posted : April 8, 2014
Last Update Posted : August 3, 2016
Sponsor:
Information provided by (Responsible Party):
Varun Dixit, Eastern Maine Medical Center

Brief Summary:

The purpose of this study is to compare two methods of pain control used during total knee joint replacement surgery. The pain medication that will be used for this study is not experimental.

The investigators will compare the single shot femoral nerve block (SSFNB) and Femoral Nerve Block (FNB) plus continuous femoral nerve catheter (CFNC) to determine which method gives patients better pain control, increasing the capability to participate in physical therapy and decreasing the consumption of other pain medication. With either the single shot or the catheter the local numbing medication called ropivacaine will be used.


Condition or disease Intervention/treatment Phase
Knee Osteoarthritis Drug: Femoral Nerve Catheters Drug: Single Shot Femoral Nerve Blocks Not Applicable

Detailed Description:

The study will be a randomized controlled blinded study with a sham control arm. The patients will be randomized to either a single shot FNB with placement of a catheter on the skin (sham control) or a conventional CFNC with catheter.

The group with SSFNB will receive a femoral nerve block before the surgery in the pre-operative area guided by a nerve stimulator and ultrasound. A bolus of 0.5 % ropivacaine will be injected around the femoral nerve. A catheter would be placed on the skin, without penetration, with occlusive dressing applied over the site. A standard size saline bag will be placed on the pump but will not be turned on. The tubing will be opaque and a bag will be placed over the pump to blind the patient to the medication, or lack of medication, being administered. The patient, nursing staff and physical therapists will be blinded to the presence of a sham catheter. The infusion will be labelled 'Study Drug R' or 'Study Drug N' in the electronic medicine prescription.

The group randomized with active drug by CFNB would have a continuous femoral catheter placed using nerve stimulator and ultrasound. Catheter will be bolused with 0.5 % ropivacaine around the femoral nerve and occlusive dressing applied over the catheter.

After placement of the femoral nerve block patients will be transported to the operating room and spinal anesthesia with bupivacaine and fentanyl will be performed. Intra-operative sedation of propofol infusion will be titrated to the discretion of the anaesthesia team. Patients will receive scheduled as well as rescue analgesia as per clinical pathway protocol.

Patients with CFNB will receive ropivacaine 0.2% infusion (the infusion rate will be dependent on the clinical judgement of the anaesthesiologist) in the post anaesthesia care unit (PACU) after the spinal anaesthesia has worn off. The infusion will be continued for the duration of the catheter, 4am POD one. Patients with SSFNB will not receive any infusion through the sham catheter.

The catheters will be removed on post-operative day (POD) one at about 8 am. Patient's pain score using visual analogue score (VAS) will be assessed. Functional status will be assessed by the physical therapist on POD one. The therapist will assess and document the distance walked, assistive device used, level of assist needed to ambulate, and knee proprioception or continued recommendation of the knee immobilizer.

Patients will be assessed in the PACU and POD 1 and 2. Recordings will be made of total opioid consumption in morphine equivalents, VAS score from 0-10 both at rest and on participation in physical therapy, incidence of nausea and vomiting and functional status during physical therapy.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 99 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Comparison of a Single Shot Femoral Nerve Block to Femoral Nerve Block Shot Plus Continuous Femoral Nerve Catheter for Total Knee Replacement Surgery; a Randomized, Blinded Controlled Trial.
Study Start Date : April 2014
Actual Primary Completion Date : September 2015
Actual Study Completion Date : December 2015

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Active Comparator: Femoral Nerve Catheters
Patients will receive a Single Shot Femoral Nerve Block along with a conventional continuous femoral nerve catheter
Drug: Femoral Nerve Catheters

Catheter will be bolused with 0.5 % ropivacaine around the femoral nerve and occlusive dressing applied over the catheter.

Patients with CFNB will receive ropivacaine 0.2% infusion (the infusion rate will be dependent on the clinical judgement of the anaesthesiologist)

Other Name: 0.5% ropivacaine bolus followed by 0.2% infusion

Drug: Single Shot Femoral Nerve Blocks
The group with SSFNB will receive a femoral nerve block before the surgery in the pre-operative area guided by a nerve stimulator and ultrasound. A bolus of 0.5 % ropivacaine will be injected around the femoral nerve.
Other Name: 0.5% ropivacaine

Active Comparator: Single Shot Femoral Nerve Blocks
Patients will receive a Single Shot Femoral Nerve Block and a sham catheter post op.
Drug: Single Shot Femoral Nerve Blocks
The group with SSFNB will receive a femoral nerve block before the surgery in the pre-operative area guided by a nerve stimulator and ultrasound. A bolus of 0.5 % ropivacaine will be injected around the femoral nerve.
Other Name: 0.5% ropivacaine




Primary Outcome Measures :
  1. Pain [ Time Frame: 48 hours post operatively ]
    Pain Analog Scale- 0-10 were 10 is the worst possible pain and 0 is no pain at all.


Other Outcome Measures:
  1. Restfulness of sleep [ Time Frame: 8 AM post op day 1 ]
    Patients will be asked if they had difficulty sleeping because of pain.

  2. Nausea and Vomiting [ Time Frame: 8 AM post op day 1 ]
    Nausea and Vomiting- Written questionnaire administer to patient. Did the patient experience Nausea? Yes/No. Using scale 0- no nausea, 1- nausea no vomiting, 2-vomiting, 3- persistent vomiting.

  3. Distance Walked [ Time Frame: 8 AM post op day 1, 48 hours post op, 3 months post op ]
    Distance walked- Distance will be measured in meters and assistive device used (including knee immobilizer)

  4. Level of Assist for Ambulation [ Time Frame: 8 AM post op day 1, 48 hours post op, 3 months post op ]
    Level of Assist for Ambulation- Independent (no device, timely, safely), modified independent (assistive device, safely or timeliness issues) supervision (requires standby assist, cueing), minimal assist (patient expends 75% of effort needed to completed task) , moderate assist (patient expends 50-74% of effort needed to completed task), max assist (patient expends 25-49% of effort needed to completed task), total assist (patient expends >25% of the effort needed to complete task).

  5. Hours until knee immobilizer is discharged [ Time Frame: 8 AM post op day 1, 48 hours post op, 3 months post op ]
    Hours until knee immobilizer is discharged - As a gauge of knee proprioception and quad strength the physical therapist will discharge the knee immobilizer when the patient can safely mobilize without the brace. The hours from surgery to discharge will be measured and >24 hours after surgery will be considered delayed discharge where <24 hours post op will be considered satisfactory.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adults (18-80 years old)
  • Scheduled to undergo primary unilateral TKA with Parapatellar approach
  • Patient agrees to participate in the study
  • Effective femoral nerve block
  • No contraindication for spinal or regional anesthesia

Exclusion Criteria:

  • History of opioid dependence or current chronic analgesic therapy (daily use >4 weeks
  • Allergy to study medications
  • Known hepatic or renal insufficiency/disease
  • Peripheral neuropathy
  • Morbid obesity (BMI >40 kg/m2)
  • Unable to comply with study protocol
  • Pregnancy
  • Incarceration

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02106481


Locations
Layout table for location information
United States, Maine
Eastern Maine Medical Center
Bangor, Maine, United States, 04401
Sponsors and Collaborators
Eastern Maine Medical Center
Investigators
Layout table for investigator information
Principal Investigator: Varun Dixit, MD Eastern Maine Medical Center
Additional Information:
Layout table for additonal information
Responsible Party: Varun Dixit, Anesthesiologist, Eastern Maine Medical Center
ClinicalTrials.gov Identifier: NCT02106481    
Other Study ID Numbers: 14-1-M-255
First Posted: April 8, 2014    Key Record Dates
Last Update Posted: August 3, 2016
Last Verified: August 2016
Keywords provided by Varun Dixit, Eastern Maine Medical Center:
TKA
TKR
Knee OA
pain management
Femoral Nerve Catheter
Single Shot Femoral Nerve Blocks
Additional relevant MeSH terms:
Layout table for MeSH terms
Osteoarthritis
Osteoarthritis, Knee
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Ropivacaine
Anesthetics, Local
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents